Nuformix plc (LON:NFX – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as GBX 0.15 ($0.00) and last traded at GBX 0.15 ($0.00), with a volume of 2412456 shares traded. The stock had previously closed at GBX 0.16 ($0.00).
Nuformix Trading Down 2.6 %
The firm has a 50 day simple moving average of GBX 0.17 and a 200 day simple moving average of GBX 0.20. The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of £1.24 million, a PE ratio of -1.63 and a beta of 1.20.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Featured Stories
- Five stocks we like better than Nuformix
- How is Compound Interest Calculated?
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What is a SEC Filing?
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
